Back to search

Bugs Bioscience Limited

08911333

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
Incorporated 25/02/2014

Compliance

Last accounts

28/02/2025

total exemption full

Next accounts due

30/11/2026

On track

Confirmation statement

Last: 05/02/2026

Due 19/02/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Jason Hinds

director · Since 04/04/2014

RESEARCH SCIENTIST

BRITISH · ENGLAND · Age 55

Mr Graham Robert Snudden

director · Since 04/04/2014

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 62

Also on 5 other boards

Mr Graham Robert Snudden

secretary · Since 22/04/2015

Also on 5 other boards

Mr Mark Cranmer

director · Since 09/05/2018

DIRECTOR OF JOINT RESEARCH AND ENTERPRIS

BRITISH · ENGLAND · Age 45

Persons with Significant Control

Mr Graham Robert Snudden

25–50% shares

British · England · Age 62

2, Royal College Street, London, NW1 0NH

Notified 06/04/2016

Dr Jason Hinds

25–50% shares

British · England · Age 55

2, Royal College Street, London, NW1 0NH

Notified 25/07/2023

St George's Hospital Medical School

25–50% shares

Cranmer Terrace, Cranmer Terrace, London, SW17 0RE

Reg: X66491 · Na · Exempt Charity

Notified 25/07/2023

CompanyRankvs 849+ SIC 72110 peers
65

Financial strength72th percentile among SIC peers · 18/25
Employees0th percentile among SIC peers · 0/15
LiquidityCurrent ratio 58.58× · 20/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
849Bugs Bioscience Limited
65
How is this score calculated?
Financial strength18/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 28/02/2025

Net Worth

£32k

Balance sheet strength

Cash

£31k

Cash in the bank

Net Current Assets

£32k

Working capital

Current Assets

£32k

Current Liabilities

£550

Debtors

£1k

Tax at Year End(2021)

Corp tax£5k

Balance Sheet

Assets less current liabilities£32k
Signed by Mr Graham Robert Snudden 10 June 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202558.58-£6k
20243.83-£25k
20232.36-£76k
20222.21+£5k
202116.93-£35k
202011.46—

Derived from filed accounts. Not audited figures.